Farmers & Merchants Investments Inc’s Nektar Therapeutics NKTR Stock Holding History

Farmers & Merchants Investments Inc’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-8	Closed	-$67	–	1781
2023 Q3	$67	Hold	8	–	–	﹤0.01%	1748
2023 Q2	$65	Hold	8	–	–	﹤0.01%	1757
2023 Q1	$79	Hold	8	–	–	﹤0.01%	1736
2022 Q4	$255	Hold	8	–	–	﹤0.01%	1717
2022 Q3	$0	Buy	+8	New	+$476	﹤0.01%	1680
2019 Q4	–	Sell	-6	Closed	-$2K	–	868
2019 Q3	$2K	Hold	6	–	–	﹤0.01%	820
2019 Q2	$3K	Hold	6	–	–	﹤0.01%	804
2019 Q1	$3K	Buy	6 +2	+50%	+$1.19K	﹤0.01%	802
2018 Q4	$2K	Hold	4	–	–	﹤0.01%	790
2018 Q3	$4K	Hold	4	–	–	﹤0.01%	760
2018 Q2	$3K	Buy	+4	New	+$4.61K	﹤0.01%	800

Other funds holding NKTR

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Farmers & Merchants Investments Inc's NKTR Position: Q4 2023 in Review

Farmers & Merchants Investments Inc sold out of Nektar Therapeutics (NKTR) in Q4 2023, closing a stake of 8 shares — an estimated $67 sold.

Farmers & Merchants Investments Inc first reported a position in NKTR in Q2 2018 and held it in 11 quarters. The position peaked at $4K in Q3 2018. 125 funds tracked by Wall St. Rank hold NKTR as of Q4 2023.

Farmers & Merchants Investments Inc reported no remaining Nektar Therapeutics position as of Q4 2023 after selling out during the quarter.
Farmers & Merchants Investments Inc sold 8 Nektar Therapeutics shares in Q4 2023, an estimated $67.
Farmers & Merchants Investments Inc first reported a position in Nektar Therapeutics in Q2 2018 and held it in 11 quarters.
Farmers & Merchants Investments Inc's Nektar Therapeutics position peaked at $4K in Q3 2018.
125 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2023.

Based on Farmers & Merchants Investments Inc's 13F filing for Q4 2023, filed 23 Jan 2024.